TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
TGTX on Nasdaq
Shares outstanding
158,835,667
Price per share
$28.47
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
83,896,231
Total reported value
$2,501,130,540
% of total 13F portfolios
0%
Share change
+2,347,966
Value change
+$64,780,076
Number of holders
258
Price from insider filings
$28.47
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 13% $883,115,925 20,134,882 BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 10% $684,061,613 15,596,480 The Vanguard Group 31 Dec 2024
STATE STREET CORP 5.1% +8% $292,634,861 +$24,085,260 8,100,619 +9% STATE STREET CORPORATION 30 Sep 2025

As of 31 Dec 2025, 258 institutional investors reported holding 83,896,231 shares of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX). This represents 53% of the company’s total 158,835,667 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) together control 46% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 14% 21,848,462 +2.6% 0.01% $651,302,651
VANGUARD GROUP INC 10% 15,841,002 +2.1% 0.01% $472,220,271
STATE STREET CORP 5.3% 8,479,999 +4.7% 0.01% $252,788,770
Clearbridge Investments, LLC 2.2% 3,448,033 -26% 0.08% $102,785,853
GEODE CAPITAL MANAGEMENT, LLC 2.1% 3,403,866 -1.2% 0.01% $101,482,782
Soleus Capital Management, L.P. 2% 3,139,312 -18% 4% $93,582,891
GOLDMAN SACHS GROUP INC 1.3% 2,051,132 +35% 0.01% $61,144,244
CONGRESS ASSET MANAGEMENT CO 1.2% 1,922,410 0.4% $57,307,042
MORGAN STANLEY 0.95% 1,503,037 +20% 0% $44,805,561
Pictet Asset Management Holding SA 0.92% 1,461,048 -9.2% 0.04% $43,553,841
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.83% 1,311,689 +0.12% 0.01% $39,101,449
JANE STREET GROUP, LLC 0.61% 969,975 -14% 0.03% $28,914,955
Nuveen, LLC 0.6% 953,206 +34% 0.01% $28,415,072
Bank of New York Mellon Corp 0.57% 898,409 +3% 0% $26,781,579
Squarepoint Ops LLC 0.54% 852,522 +69% 0.05% $25,413,681
PRINCIPAL FINANCIAL GROUP INC 0.53% 847,787 +8.1% 0.01% $25,272,531
EVENTIDE ASSET MANAGEMENT, LLC 0.45% 716,414 -25% 0.33% $21,356,301
BNP PARIBAS FINANCIAL MARKETS 0.43% 683,653 0% 0.01% $20,379,696
Penn Capital Management Company, LLC 0.34% 538,117 +3.2% 1.3% $16,082,092
UBS Group AG 0.34% 537,019 -13% 0% $16,008,537
BANK OF MONTREAL /CAN/ 0.32% 512,378 -0.05% 0.01% $15,273,988
CITIGROUP INC 0.3% 483,525 -35% 0.01% $14,413,881
DIMENSIONAL FUND ADVISORS LP 0.3% 472,787 +1725% 0% $14,093,781
PUBLIC SECTOR PENSION INVESTMENT BOARD 0.3% 470,286 -11% 0.05% $14,019,226
Bridgewater Associates, LP 0.3% 469,855 +37% 0.05% $14,006,378

Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 83,896,231 $2,501,130,540 +$64,780,076 $29.81 258
2025 Q3 99,010,950 $3,576,852,552 -$93,639,711 $36.12 350
2025 Q2 101,251,004 $3,644,068,318 +$105,165,687 $35.99 353
2025 Q1 98,398,350 $3,879,797,019 +$91,891,626 $39.43 370
2024 Q4 96,867,606 $2,915,819,583 -$82,204,584 $30.10 325
2024 Q3 101,373,709 $2,371,765,800 -$15,722,787 $23.39 299
2024 Q2 93,092,725 $1,656,135,243 +$59,195,672 $17.79 249
2024 Q1 90,107,125 $1,370,540,354 -$16,725,794 $15.21 234
2023 Q4 90,283,479 $1,542,093,372 +$61,590,148 $17.08 228
2023 Q3 90,485,069 $756,218,410 -$269,126,636 $8.36 230
2023 Q2 88,259,288 $2,192,377,673 -$88,730,550 $24.84 240
2023 Q1 94,743,370 $1,424,911,575 +$49,874,888 $15.04 207
2022 Q4 93,352,835 $1,104,363,051 -$26,457,664 $11.83 194
2022 Q3 98,647,609 $583,969,618 -$39,974,731 $5.92 168
2022 Q2 106,408,531 $452,245,708 -$5,017,128 $4.25 161
2022 Q1 100,868,318 $959,384,130 -$98,040,474 $9.51 169
2021 Q4 100,212,572 $1,902,689,658 +$38,904,536 $19.00 185
2021 Q3 96,326,356 $3,203,956,013 -$38,579,975 $33.28 213
2021 Q2 96,046,069 $3,725,506,174 -$125,135,262 $38.79 232
2021 Q1 98,807,721 $4,765,076,153 -$16,595,617 $48.20 233
2020 Q4 99,923,648 $5,198,116,671 +$669,912,268 $52.02 246
2020 Q3 87,699,838 $2,345,820,172 +$119,192,436 $26.76 180
2020 Q2 83,924,060 $1,633,423,112 +$391,433,047 $19.48 172
2020 Q1 64,801,021 $638,667,081 +$63,397,220 $9.84 143
2019 Q4 58,195,962 $645,923,679 +$107,765,143 $11.10 132
2019 Q3 48,424,458 $271,901,414 -$14,799,642 $5.62 110
2019 Q2 50,242,483 $434,393,474 +$21,792,679 $8.65 113
2019 Q1 48,122,755 $386,871,816 +$29,442,149 $8.04 108
2018 Q4 48,890,458 $200,441,948 -$49,052 $4.10 108
2018 Q3 47,668,777 $266,945,761 +$31,954,202 $5.60 123
2018 Q2 40,599,564 $533,908,273 +$25,285,157 $13.15 125
2018 Q1 38,595,106 $548,041,984 +$48,773,765 $14.20 120
2017 Q4 35,773,173 $293,344,147 -$8,655,319 $8.20 104
2017 Q3 35,616,666 $422,040,218 +$16,175,615 $11.85 98
2017 Q2 34,343,930 $345,174,620 +$34,148,838 $10.05 104
2017 Q1 30,793,239 $358,729,155 +$141,497,698 $11.65 94
2016 Q4 21,691,451 $100,862,746 -$33,390,293 $4.65 85
2016 Q3 27,043,519 $209,317,474 -$5,208,399 $7.74 70
2016 Q2 27,922,586 $169,210,192 -$14,367,082 $6.06 84
2016 Q1 29,568,032 $251,891,278 +$21,737,929 $8.52 77
2015 Q4 26,883,969 $320,726,141 -$10,358,883 $11.93 86
2015 Q3 28,032,706 $282,560,154 +$33,018,222 $10.08 81
2015 Q2 23,870,474 $396,063,213 +$22,614,129 $16.59 88
2015 Q1 21,468,878 $332,291,565 +$41,921,139 $15.48 79
2014 Q4 18,705,472 $296,099,998 +$46,976,429 $15.84 75
2014 Q3 15,479,378 $165,165,645 +$26,934,922 $10.67 66
2014 Q2 12,980,577 $121,887,208 +$12,525,355 $9.39 65
2014 Q1 11,640,376 $80,287,912 +$31,815,255 $6.90 47